Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.

Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.

Item
http://www.wikidata.org/entity/Q36544778
Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinomaEffective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes.Control of B lymphocyte development and functions by the mTOR signaling pathways.Targeting mTOR for the treatment of B cell malignancies.Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells.Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling.A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations.Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An UpdateBiological Aspects of mTOR in Leukemia
P2860

Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.

Item
http://www.wikidata.org/entity/Q36544778
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Co-targeting of Bcl-2 and mTOR ...... acute lymphoblastic leukemia.
@ast
Co-targeting of Bcl-2 and mTOR ...... acute lymphoblastic leukemia.
@en
type
label
Co-targeting of Bcl-2 and mTOR ...... acute lymphoblastic leukemia.
@ast
Co-targeting of Bcl-2 and mTOR ...... acute lymphoblastic leukemia.
@en
prefLabel
Co-targeting of Bcl-2 and mTOR ...... acute lymphoblastic leukemia.
@ast
Co-targeting of Bcl-2 and mTOR ...... acute lymphoblastic leukemia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Co-targeting of Bcl-2 and mTOR ...... acute lymphoblastic leukemia.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932